As professionals in pharmaceutical engineering, we are challenged to develop medications and therapies more quickly and less expensively than ever before while maintaining safety and efficacy. It can be hard to know where to turn when you have an issue you cannot resolve or difficult to find your next bit of inspiration. The ISPE Annual Meeting & Expo is a great opportunity for us to come...
The pharmaceutical industry is experiencing a pivotal transformation. As professionals strive to develop therapies faster, more cost-effectively, and with greater precision, Pharma 4.0™ emerges as a powerful framework for change. This evolution is not only technological—it is cultural. It challenges organizations to become more agile, data-driven, and patient-focused.
Pharma 4.0™ represents a transformative shift within the pharmaceutical industry, redefining how medicines are developed, manufactured, and delivered. At its core, Pharma 4.0 involves the integration of advanced digital technologies...
The pharmaceutical industry faces considerable challenges throughout the development, manufacturing, and supply of medicines, largely due to the intricate and divergent global regulatory landscape. The adoption of structured data standards and utilization of cloud-based platforms offer immense potential to overcome these challenges by facilitating faster and more efficient global...
The ongoing evolution of the pharmaceutical industry, aimed at propelling the next generation of medicines requires the close collaboration with regulators, emphasizing innovation, partnership, and a continued dedication to addressing patient needs. This transformation holds the potential to guide significant advancements in the development and delivery of medicines, leading to improved...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
